• Plerixafor (AMD3100): Applied Workflows for CXCR4 Inhibition

  2026-05-25

  Plerixafor (AMD3100) is the benchmark small-molecule CXCR4 antagonist, unlocking precision in cancer metastasis inhibition and hematopoietic stem cell mobilization workflows. This article delivers step-by-step protocol optimizations, advanced use-cases, and troubleshooting strategies—bridging fundamental research and translational impact.

• Pomalidomide (CC-4047): Transforming Hematological Malignanc

  2026-05-25

  Pomalidomide (CC-4047) empowers researchers to dissect tumor microenvironment dynamics and overcome drug resistance in multiple myeloma models. This article provides executable protocols, troubleshooting strategies, and insight-driven applications to maximize the utility of APExBIO’s Pomalidomide in hematological malignancy research.

• Radicicol: A Next-Gen Tool for Precision Adipogenesis and In

  2026-05-24

  Explore how Radicicol, a potent Hsp90 inhibitor, uniquely enables advanced and reproducible modeling of adipocyte differentiation and sepsis inflammation, with mechanistic clarity and practical assay guidance. This article delivers a new perspective on Radicicol’s role in dissecting metabolic and immunological pathways.

• Exemestane: Steroidal Aromatase Inhibitor for Advanced Resea

  2026-05-23

  Exemestane empowers precise, irreversible inhibition of estrogen biosynthesis in breast cancer research and hormone-dependent studies. This guide delivers actionable protocols, troubleshooting strategies, and advanced comparative insights—enabling researchers to maximize experimental reliability and translational relevance.

• RSL3 Drives Distinct PARP1 Apoptotic Mechanisms in Ferroptos

  2026-05-22

  This study uncovers how RSL3, a ferroptosis inducer, triggers two distinct PARP1-dependent apoptotic mechanisms in cancer cells—caspase-mediated cleavage and translational suppression via m6A modification inhibition. These findings highlight a novel crosstalk between ferroptosis and apoptosis, with implications for overcoming PARP inhibitor resistance in tumors.

• Hypoxia-Driven Immunometabolism in Tumor Microenvironment: M

  2026-05-22

  This review dissects how hypoxia and metabolic reprogramming interact to create an immunosuppressive tumor microenvironment (TME), focusing on the underlying mechanisms and therapeutic prospects. The findings highlight the centrality of nutrient competition and redox balance in shaping tumor progression and immune evasion.

• Palomid 529 Enhances Cancer Research via Dual mTORC Inhibiti

  2026-05-21

  Palomid 529 (P529) empowers researchers to dissect and block the PI3K/Akt/mTOR signaling pathway, tackling tumor progression and therapy resistance with precision. Its dual mTORC1/2 inhibition and robust anti-angiogenic profile make it a cornerstone for translational cancer studies and radiotherapy enhancement.

• Prostaglandin E2: Mechanisms and Benchmarks in Inflammation

  2026-05-21

  Prostaglandin E2 (PGE2) is an endogenous lipid mediator central to inflammation research and immune regulation. APExBIO's high-purity PGE2 (SKU B7005) enables reproducible receptor binding and functional studies. This article provides atomic, referenced facts on its mechanism, assay parameters, and clinical benchmarks.

• High-Throughput BBB Permeability: LLC-PK1-MOCK/MDR1 Model Ad

  2026-05-20

  Hu et al. introduce a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and LLC-PK1-MDR1 cells, integrating lysosomal trapping correction to improve prediction of brain permeability for CNS drugs. This model demonstrates robust predictive accuracy and streamlines early-stage compound screening, offering a practical alternative to labor-intensive in vivo assessments.

• Cytoskeleton-Dependent Autophagy under Mechanical Stress: Ne

  2026-05-20

  This study uncovers the pivotal role of the cytoskeleton, particularly microfilaments, in mediating autophagy triggered by mechanical stress in human cells. The findings clarify mechanotransduction pathways and provide mechanistic context for researchers investigating calcium signaling and cellular homeostasis.

• One-step TUNEL Cy3 Kit: Precision Apoptosis Detection in Tra

  2026-05-19

  Discover how the One-step TUNEL Cy3 Apoptosis Detection Kit enables precise, translational detection of DNA fragmentation and apoptosis, uniquely bridging mechanistic insight with clinical relevance in liver injury models. Explore advanced protocols and the latest research-driven guidance.

• Melittin: Bioactive Peptide Workflows for Cancer Signal Modu

  2026-05-19

  Melittin stands out as a dual Gs inhibitor and Gi activator, providing a unique lever for dissecting cell signaling and apoptosis in cancer research. This guide details optimized workflows, troubleshooting strategies, and experimental insights that leverage Melittin's precision for high-impact studies in signal transduction and glioblastoma biology.

• High-Throughput Ionizable Lipid Optimization for mRNA Delive

  2026-05-18

  Li et al. (2024) introduce a high-throughput A3 coupling approach to synthesize and screen 623 ionizable lipids, elucidating precise structure–function relationships that dictate mRNA delivery efficiency. Their findings guide rational lipid nanoparticle design to enhance therapeutic and reporter mRNA delivery, with practical implications for gene regulation and in vivo imaging studies.

• CDK4 Phosphorylation of 4E-BP1: Chemoproteomic Insights in C

  2026-05-18

  Mitchell et al. (2019) introduce a chemoproteomic pipeline that identifies CDK4 as a novel kinase for 4E-BP1, revealing a critical mechanism underlying mTORC1-inhibitor resistance in breast cancer. Their phosphosite-specific mapping of kinase-substrate interactions advances our understanding of translational control and therapeutic targeting in oncogenic pathways.

• Diuron (SKU C6731): Reliable Toxicology & Cell Assay Researc

  2026-05-17

  This article delivers scenario-driven guidance for using Diuron (SKU C6731) in toxicology and cell viability assays, emphasizing evidence-based protocol optimization, data interpretation, and product reliability. Targeted at biomedical researchers and laboratory technicians, it addresses real-world workflow challenges and illustrates how APExBIO's Diuron underpins reproducible and sensitive toxicological studies.

553 records 17/37 page Previous Next First page 上5页 1617181920 下5页 Last page